https://spear.bio/news/spear-bio-receives-iso-134852016-certification/ 2024-07-15T00:58:01+00:00 https://spear.bio/news/spear-bio-developer-of-the-next-generation-ultrasensitive-immunodiagnostics-and-proteomics-platform-completes-raise-of-tens-of-millions-of-us-dollars-with-oversubscribed-seed-prime/ 2024-07-15T00:58:19+00:00 https://spear.bio/news/new-spear-bio-ultrasensitive-immunoassay-neutralizing-antibodies-test-kits-for-covid-variants/ 2024-07-15T00:58:44+00:00 https://spear.bio/news/spear-bio-co-founder-feng-xuan-to-present-at-vaccines-summit-this-month-in-boston/ 2024-07-15T00:59:21+00:00 https://spear.bio/news/spear-bio-expands-nab-sure-assays-to-support-study-of-sars-cov-2-variants/ 2024-07-15T00:59:34+00:00 https://spear.bio/news/spear-bio-co-founder-and-cto-to-present-at-vaccine-summit/ 2024-07-15T01:05:24+00:00 https://spear.bio/news/spear-bios-nab-sure-test-kit-aids-analysis-of-covid-19-immune-response/ 2024-07-15T01:06:12+00:00 https://spear.bio/news/spear-bio-secures-45-million-in-oversubscribed-series-a-financing-to-accelerate-product-launch-for-protein-research-and-disease-diagnostics/ 2024-07-29T12:52:52+00:00 https://spear.bio/news/immunoassay-technology-developer-spear-bio-presents-its-nab-sure-sars-cov2-neutralizing-antibody-test-kit-at-the-american-association-of-clinical-chemistrys-annual-event/ 2024-08-08T18:35:29+00:00 https://spear.bio/news/wyss-institute-at-harvard-university-launches-spear-bio/ 2024-10-24T13:37:50+00:00 https://spear.bio/news/spear-bio-launches-next-generation-ultrasensitive-immunoassay-solution-spear-ultradetect-to-transform-neurodegenerative-disease-research/ 2025-08-04T13:48:00+00:00 https://spear.bio/news/spear-bio-announces-strategic-partnership-with-bio-techne-to-accelerate-the-deployment-of-its-next-generation-immunoassay-technology/ 2025-08-04T13:48:18+00:00 https://spear.bio/events/alzheimers-association-international-conference-aaic-2025/ 2025-10-22T00:31:59+00:00 https://spear.bio/wp-content/uploads/2025/07/Screenshot-2025-07-03-095950.png https://spear.bio/wp-content/uploads/2025/07/Product-Theater-Social-Post-01-1536x803-1.png https://spear.bio/events/alzheimers-parkinsons-diseases-conference/ 2025-10-22T00:34:53+00:00 https://spear.bio/wp-content/uploads/2025/01/ADPD-2025-graphic-1024x514.png https://spear.bio/events/sfn-2025/ 2025-11-07T21:23:41+00:00 https://spear.bio/wp-content/uploads/2025/10/SfN-2025-Banner-1920-x-1080-px.svg https://spear.bio/wp-content/uploads/2025/11/Provencher-Laurel-Spear-Bio-circle-1000x1000-1.png https://spear.bio/wp-content/uploads/2025/11/Worsfold-Camilla-Spear-Bio-circle.png https://spear.bio/events/webinar/enhanced-early-alzheimers-detection-with-the-novel-spear-ultradetect-ptau-217-assay/ 2026-01-13T04:32:58+00:00 https://spear.bio/wp-content/uploads/2026/01/Nicholas-Ashton-edited.jpg https://spear.bio/wp-content/uploads/2025/11/Provencher-Laurel-Spear-Bio-circle-1000x1000-1.png https://spear.bio/events/conference/alzheimers-parkinsons-drug-development-summit/ 2026-01-13T05:14:30+00:00 https://spear.bio/wp-content/uploads/2024/07/Group-4997.png https://spear.bio/news/global-alzheimers-platform-foundation-announces-strategic-collaboration-and-partnership-with-spear-bio-for-the-transformative-bio-hermes-002-study/ 2026-01-13T05:34:24+00:00 https://spear.bio/news/formulatrix-and-spear-bio-advance-automated-ultrasensitive-protein-detection-through-ongoing-partnership/ 2026-02-07T03:15:54+00:00 https://spear.bio/events/gap-net-site-optimization-conference-2026-2/ 2026-02-12T08:26:27+00:00 https://spear.bio/wp-content/uploads/2026/02/AdobeStock_334538090-scaled.jpeg https://spear.bio/events/ad-pd-alzheimers-parkinsons-diseases-conference-2026/ 2026-03-09T15:16:33+00:00 https://spear.bio/wp-content/uploads/2026/02/800x200px.png https://spear.bio/wp-content/uploads/2026/02/Laurel-headshot.jpg https://spear.bio/wp-content/uploads/2026/02/BIO05880-scaled.jpg https://spear.bio/news/spear-bio-introduces-new-ultra-sensitive-neurodegenerative-assays-and-expands-direct-access-at-ad-pd-2026/ 2026-03-23T15:02:27+00:00 https://spear.bio/news/spear-bio-secures-fda-breakthrough-device-designation-for-its-novel-ptau-217-blood-test-advancing-scalable-solutions-for-early-alzheimers-disease-diagnosis/ 2026-04-21T18:06:08+00:00 https://spear.bio/events/webinar/enhance-neurodegenerative-detection-and-monitoring-with-bd-ptau-217-and-a-syn/ 2026-05-22T12:59:32+00:00 https://spear.bio/wp-content/uploads/2025/08/Adobe-Express-file-25.png https://spear.bio/events/aaic-2026/ 2026-07-06T15:20:11+00:00 https://spear.bio/wp-content/uploads/2026/06/aaic26-logo-site-wrapper-Edited.png https://spear.bio/wp-content/uploads/2026/01/Nicholas-Ashton-edited.jpg https://spear.bio/wp-content/uploads/2026/06/1748999893328-2.jpeg https://spear.bio/events/meet-spear-bio-at-the-5th-als-drug-development-summit/ 2026-07-29T14:27:47+00:00 https://spear.bio/wp-content/uploads/2026/05/SpearBio-Program-Partner.png https://spear.bio/wp-content/uploads/2024/07/Group-4997.png https://spear.bio/wp-content/uploads/2026/05/Image-25.jpeg https://spear.bio/news/bd-ptau-217-assay-rd-100-award/ 2026-08-11T13:16:57+00:00 https://spear.bio/news/spear-bio-to-unveil-novel-alzheimers-disease-immunoassays-and-fully-automated-instrument-platform-at-aaic-2026/ 2026-08-11T18:47:34+00:00